Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize a platform that can match cancer patients to the right drug and aid… Read More
NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance of stem cells in drug development. With the acquisition, NanoSurface… Read More